Allosteric effect on muscarinic M2-receptors of derivatives of the alkane-bis-ammonium compound W84: comparison with bispyridinium-type allosteric modulators

Abstract The symmetrically shaped W84 = N,N,N′,N′-tetramethyl-N,N′-bis-(3-phthalimido-propyl)-N,N′-hexane-1,6-diyl-bis-ammonium dibromide is a potent allosteric stabilizer of antagonist-binding to cardiac muscarinic M2-receptors. The ability of unilaterally shortened W84 derivatives to allosterically retard the dissociation of [3H]N-methylscopolamine ([3H]NMS) from M2-receptors was determined in porcine cardiac membranes (3 mM MgHPO4, 50 mM TrisHCl, pH 7.3, 37°C). Shortening was accompanied by a reduction of the allosteric activity. For instance, W84 prolonged the half-life of [3H]NMS dissociation (control t 1 2 = 2.0 min) by a factor of 2 at a concentration of EC50 = 1.3 μM, whereas a derivative unilaterally lacking phthalimidopropyldimethylammonium was 40-fold less potent. It is concluded that the whole W84 molecule interacts with the allosteric site of the receptor. The structure-activity relationships found with this series of agents did not parallel findings made previously with similarly modified derivatives of the bispyridinium compound DUO 3, (E,E)-1,1′- (1,3-propanediyl)-bis[4-[[(2,6-dichlorobenzoxyl)imino]-methyl]pyridinium] dibromide, despite considerable similarity with respect to molecular shape and charge distribution.

[1]  E. El-Fakahany,et al.  Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.

[2]  O. Wassermann,et al.  Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds. , 1969, European journal of pharmacology.

[3]  E. El-Fakahany,et al.  Allosteric antagonists of the muscarinic acetylcholine receptor. , 1991, Biochemical pharmacology.

[4]  E. El-Fakahany,et al.  Allosteric interaction of dynorphin and myelin basic protein with muscarinic receptors. , 1993, Pharmacology.

[5]  V. Bertolasi,et al.  Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands. , 1987, Molecular pharmacology.

[6]  J. Proska,et al.  Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. , 1994, Molecular pharmacology.

[7]  U. Holzgrabe,et al.  Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors. , 1994, Journal of medicinal chemistry.

[8]  K. Mohr,et al.  Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication. , 1988, Pharmacology & toxicology.

[9]  D. Mash,et al.  Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. , 1992, Molecular pharmacology.

[10]  O. Wassermann,et al.  Action of atropine and some hexane-1.6-bis-ammonium derivatives upon the toxicity of DFP im mice. , 1968, European Journal of Pharmacology.

[11]  G. Biggio,et al.  Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors. , 1990, European journal of pharmacology.

[12]  C. Forray,et al.  Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands. , 1992, Molecular pharmacology.